MTC
ABBV icon

Matrix Trust Company’s AbbVie ABBV Stock Holding History

Matrix Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.52M Buy
13,447
+892
+7% +$229K 0.51% 30
2026
Q2 		$3.16M Sell
12,555
-989
-7% -$213K 0.46% 31
2026
Q1 		$2.95M Buy
13,544
+304
+2% +$67.4K 0.49% 29
2025
Q4 		$3.02M Sell
13,240
-1,025
-7% -$233K 0.5% 27
2025
Q3 		$3.3M Sell
14,265
-329
-2% -$67K 0.52% 26
2025
Q2 		$2.71M Buy
14,594
+671
+5% +$125K 0.43% 32
2025
Q1 		$2.92M Buy
13,923
+84
+0.6% +$16.3K 0.49% 25
2024
Q4 		$2.46M Buy
13,839
+420
+3% +$77.2K 0.43% 29
2024
Q3 		$2.65M Buy
13,419
+102
+0.8% +$19K 0.5% 25
2024
Q2 		$2.28M Buy
13,317
+89
+0.7% +$14.7K 0.52% 22
2024
Q1 		$2.41M Buy
13,228
+14
+0.1% +$2.41K 0.54% 19
2023
Q4 		$2.05M Sell
13,214
-88
-0.7% -$12.8K 0.48% 25
2023
Q3 		$1.98M Buy
13,302
+141
+1% +$20.7K 0.52% 22
2023
Q2 		$1.77M Buy
13,161
+484
+4% +$71K 0.46% 28
2023
Q1 		$2.02M Buy
12,677
+840
+7% +$128K 0.54% 18
2022
Q4 		$1.91M Buy
11,837
+3,675
+45% +$563K 0.48% 19
2022
Q3 		$1.1M Buy
8,162
+2,499
+44% +$359K 0.31% 24
2022
Q2 		$867K Buy
5,663
+3,045
+116% +$465K 0.24% 24
2022
Q1 		$424K Buy
+2,618
New +$380K 0.1% 20

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Matrix Trust Company's ABBV Position: Q3 2026 in Review

Matrix Trust Company increased its AbbVie (ABBV) stake by 7.1% in Q3 2026, buying an estimated $229K and bringing the position to 13,447 shares worth $3.52M. The position accounts for 0.51% of the portfolio, ranked #30.

Matrix Trust Company first reported a position in ABBV in Q1 2022 and has held it in 19 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Matrix Trust Company held 13,447 shares of AbbVie worth $3.52M as of Q3 2026.
  • Matrix Trust Company bought 892 AbbVie shares in Q3 2026, an estimated $229K.
  • AbbVie made up 0.51% of Matrix Trust Company's portfolio in Q3 2026, its #30 holding.
  • Matrix Trust Company first reported a position in AbbVie in Q1 2022 and has held it in 19 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Matrix Trust Company's 13F filing for Q3 2026, filed 7 Oct 2026.